ILLUSIO on Equifund CFP

The world's first augmented reality platform for cosmetic surgery

Raise to date: $227,210

Reporting Date: 05/03/2020

Key Stats

Minimum Raise

$20,000

Maximum Raise

$1,070,000

Likelihood of Max Unlikely
Start Date

02/25/2020

Stop Date

05/01/2020

Days Remaining

Closed

Security Type

Common Stock

Investment Minimum

$700

Deal Type

No Review


Investment Summary

Status

Confirmed Closed

# of Investors

189

% of Minimum Raised

1,136%

% of Maximum Raised

21%

Dollars Per Day to Reach Max

N/A

DPD* Committed

$3,443

DPD* Category

$0

DPD* All Companies

$906

Kingscrowd Momentum

$227,210

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

Illusio, the world’s first augmented reality platform for cosmetic surgery, is raising funds on Equifund Crowd Funding Portal. The company has a pre-money valuation of $15 million and owns a state-of-the-art patented technology that increases the visualization for procedures like liposuction and breast implants. Using Illusio technology, the doctors can present real-time three-dimensional visualizations to patients. Illusio was founded by Ethan Winner, Kyle Song M.D., and Preston Platt. The current round of crowdfunding of Illusio has a minimum raise of $20,000 and a maximum raise of $1,070,000, and the funds will be used towards marketing, advertising, leasing costs, repayment of indebtedness, and general working capital. Illusio has a strategic partnership with Mentor Worldwide, a global brand in breast implants.

Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add ILLUSIO on Equifund CFP
Follow company
Follow ILLUSIO on Equifund CFP
INVEST NOW

Get access to the first and only premium analytics and rating platform that enables informed startup investments.

Become an Informed Investor